Posts By: Alnylam Pharmaceuticals

August 19, 2025 Alnylam Announces Expansion of U.S. Manufacturing Facility Read More ›
December 19, 2023 Community Spotlight: GenUnity – A Community-Based Model of Change Through Alnylam Challengers, Alnylam partners with organizations like GenUnity which works to unlock community-centered innovation Read More ›
October 26, 2023 Alnylam Named a Top Science Employer by Science Magazine for the 5th Year in a Row Alnylam has been named a Science Magazine Top Employer for the 5th year in a row. Read More ›
August 9, 2023 RNAi Therapeutics on the European Pharmaceutical Review Podcast Paul Nioi, PhD, VP of Discovery and Translational Research discussed RNAi therapeutics on the The European Medical Review Podcast. Read More ›
July 11, 2023 Alnylam Named a Best Workplace for Innovators for the 3rd Year in a Row by Fast Company Alnylam has been named a Fast Company Best Workplace for Innovators for 2023, our 3rd year in a row. Read More ›
June 23, 2023 Alnylam in the Community: CASPAR Partnership Highlight Alnylam has partnered with community organization CASPAR (Cambridge And Somerville Programs for Addiction Recovery) for many years. Read More ›
March 29, 2023 Leading by Example in Gender Diversity Among Executive Leadership Alnylam ranked #1 among MA public companies in board of directors gender diversity and #3 in executive leadership gender diversity in the 2023 WPG report.   Read More ›
March 10, 2023 Harnessing Human Genetics to Power the Next Wave of RNAi Therapeutics Learn about how Alnylam's approach to genetic validation and how it is using genetics to power the development of the next wave of RNAi therapeutics Read More ›
February 28, 2023 The Importance of Self-Advocacy: Supporting Patients and Caregivers in Their Rare Disease ... Rare Disease Day unites the community to spread awareness and support the millions of people worldwide living with with a rare disease. Read More ›
January 31, 2023 Alnylam Named to Bloomberg's Gender-Equality Index for 3rd Year in a Row Alnylam has been named to Bloomberg's Gender Equality Index (GEI) for the 3rd year in a row. Read More ›